Big Pharma Split Corp. vs Spackman Equities Group
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Spackman Equities Group is the larger company by market value: $26 M against $25 M for Big Pharma Split Corp., 1.1 times as much (market caps of Oct 31, 2026).
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Side by side
| Measure | Big Pharma Split Corp. PRM.TO · #23,703 in the world | Spackman Equities Group SQG.V · #23,469 in the world |
|---|---|---|
| Profile | ||
| Country | 🇨🇦 Canada | 🇨🇦 Canada |
| Sector | Financial Services | Financial Services |
| Industry | Asset Management | Asset Management |
| Founded | — | — |
| Size | ||
| Market cap | $25 M | $26 M |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026 | Market cap Oct 2026 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Big Pharma Split Corp. or Spackman Equities Group?
Spackman Equities Group is the larger company by market value: $26 M against $25 M for Big Pharma Split Corp., 1.1 times as much (market caps of Oct 31, 2026).
More about Big Pharma Split Corp.
More about Spackman Equities Group
Sources#
Every figure on this page comes from these, with the date shown next to it.